# NuPathe

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nupathe

- Industry: Pharmaceuticals
- Headquarters: Conshohocken, US
- Website: www.nupathe.com
- Total disclosed funding: $44M
- Latest round: Series B (Jul 8, 2008)
- Investors on record: 7

## About

NuPathe Inc. is based in the US and operates as a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.

## Funding rounds

- Series B, Jul 8, 2008, $35M — Safeguard Scientifics, Quaker Partners Management, Ben Franklin Technology Partners, SR One, Battelle Ventures, BioAdvance, Birchmere
- Series A, Sep 13, 2006, $8.6M — Safeguard Scientifics, Quaker Partners Management, Ben Franklin Technology Partners, BioAdvance, Birchmere

## Investors

- Safeguard Scientifics (https://capitalatlas.ai/funds/safeguard-scientifics) — Series A, Series B
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series A, Series B
- Ben Franklin Technology Partners (https://capitalatlas.ai/funds/ben-franklin-technology-partners) — Series A, Series B
- BioAdvance (https://capitalatlas.ai/funds/bioadvance) — Series A, Series B
- Birchmere (https://capitalatlas.ai/funds/birchmere) — Series A, Series B
- SR One (https://capitalatlas.ai/funds/sr-one) — Series B
- Battelle Ventures (https://capitalatlas.ai/funds/battelle-ventures) — Series B